Table 1 |
|||
|
Mendelian disease gene identification approaches |
|||
|
Approach |
Applies to |
Advantages |
Disadvantages |
|
|
|||
|
Candidate gene |
Any disease |
Easy to perform for one or two genes; requires no mapping, can directly identify the causative variant/mutation |
Relies heavily on current biological knowledge; success rate very low |
|
Genetic mapping by karyotyping |
Any disease |
Easy to perform; no familial cases required; can detect (large) balanced events |
Low resolution, only detects large chromosomal aberrations; mutation detection requires second step |
|
Genetic mapping by linkage analysis |
Inherited disease |
Easy to perform |
Requires large families, often identifies large loci; mutation detection requires second step |
|
Genetic mapping by homozygosity mapping |
Recessive monogenic diseases |
Small families can be used |
Most useful for consanguineous families; often identifies large loci; mutation detection requires second step |
|
Genetic mapping by CNV analysis |
Monogenic/monolocus disease |
High resolution CNV screening; no familial cases required; can potentially identify small loci |
Only investigates CNVs; cannot detect balanced events, no base-pair resolution; mutation detection requires second step |
|
Whole exome sequencing (WES) |
Any disease |
Base-pair resolution exome-wide; detects most types of genomic variation; can directly identify the causative variant/mutation |
Unable to detect non-coding variants; limited resolution for CNVs and other structural variation; coverage variability due to enrichment process; relatively expensive |
|
Whole genome sequencing (WGS) |
Any disease |
Base-pair resolution genome-wide; detects all types of genomic variation; can directly identify the causative variant/mutation |
Data analysis complex; even more expensive than exome sequencing |
|
|
|||
|
Gilissen et al. Genome Biology 2011 12:228 doi:10.1186/gb-2011-12-9-228 |
|||